Hvad betyder "Ryd"?
Dyret bærer ikke mutationen. Det vil ikke udvikle sygdommen og vil ikke give det videre.
Cerebellar Hypoplasia (CHP) in Eurasier dogs is a genetic condition affecting coordination and balance. Early DNA testing for CHP helps breeders identify carriers and prevent passing this neurological disorder to puppies. By using a reliable DNA test, Eurasier owners can ensure healthier litters and improve overall breed health. Understanding the genetic risks of CHP allows for informed breeding decisions and better management of affected dogs. Regular screening is essential for maintaining the Eurasier’s quality of life and vitality. Invest in a DNA test for Cerebellar Hypoplasia to protect your Eurasier’s future. Stay proactive in safeguarding your dog’s health with advanced genetic testing.
The DNA test for Cerebellar Hypoplasia in Eurasier (CHP) helps identify carriers of this genetic disorder. CHP affects the development of the cerebellum, leading to coordination and balance issues in affected dogs. By testing, breeders can make informed decisions to avoid producing affected puppies. Early detection through DNA testing promotes healthier breeding practices within the Eurasier community. This test is a valuable tool for maintaining the breed’s overall health and well-being.
Denne DNA-test er inkluderet fra vores pakke Basic — og er også en del af pakkerne Basic, Standard, Advanced, Complete.
Se DNA-testpakker →Cerebellar Hypoplasia (CHP) is a neurological condition characterized by the underdevelopment of the cerebellum, a part of the brain responsible for coordinating movement and balance. In Eurasier dogs, this genetic disorder can lead to a range of motor difficulties, affecting their ability to walk, run, and perform other physical activities. Symptoms often manifest early in a dog’s life, typically within the first few months, and can vary in severity from mild to profound impairment.
The condition is caused by specific genetic mutations that disrupt normal cerebellar development. These mutations can be identified through DNA testing, which allows breeders and owners to determine the genetic predisposition of their dogs towards CHP. Understanding the genetic basis of this condition is crucial for responsible breeding practices, as it helps reduce the risk of passing on the disorder to future generations.
Dogs with Cerebellar Hypoplasia may exhibit a range of symptoms that can include uncoordinated movements, difficulty maintaining balance, and an abnormal gait. Some affected dogs may also display tremors or exhibit a wide stance when walking. Diagnosis typically involves a combination of clinical examination and genetic testing to confirm the presence of mutations associated with the condition. It is essential for owners to consult with a veterinarian if they suspect their dog may be affected, as early diagnosis can aid in managing the symptoms effectively.
While there is currently no cure for Cerebellar Hypoplasia, various management strategies can help improve the quality of life for affected dogs. These may include physical therapy, which can enhance muscle strength and coordination, and environmental modifications to create a safe living space. Providing a supportive and loving environment is crucial, as dogs with CHP can lead fulfilling lives despite their challenges.
DNA testing plays a vital role in breeding programs aimed at minimizing the incidence of Cerebellar Hypoplasia in Eurasier dogs. By identifying carriers of the genetic mutations linked to this condition, breeders can make informed decisions to avoid breeding practices that may perpetuate the disorder. This proactive approach not only helps maintain the health of the breed but also promotes overall responsible breeding ethics.
Cerebellar Hypoplasia in Eurasier dogs is a serious genetic condition that impacts their neurological function and quality of life. Through understanding the genetic basis, symptoms, and management of CHP, owners and breeders can work together to address this disorder. DNA testing serves as a critical tool in identifying at-risk animals and fostering healthier breeding practices, ultimately leading to a stronger and more resilient breed.
Dyret bærer ikke mutationen. Det vil ikke udvikle sygdommen og vil ikke give det videre.
Nej. Dyret er generelt sundt, men kan overføre mutationen til dens afkom.
Den bærer to muterede kopier. Kliniske tegn forventes afhængig af sygdommen. Det skal ikke avles.
Nogle sygdomme er kønsbundne, så deres udtryk varierer afhængigt af dyrs køn.
This DNA test detects the mutation associated with Cerebellar Hypoplasia In Eurasier (CHP-E) in order to identify clear, carrier, or at-risk animals.
DNA-test hjælper opdrættere med at planlægge sikrere parringer og reducerer risikoen for at overføre mutationen til afkom.
Den nedarvede tilstand, der er rapporteret for denne test, er autosomal recessiv.
This test analyses the mutation VLDLR c.1713delC.
Ikke nødvendigvis. Fortolkningen afhænger af arvemønsteret og den resulterende genotype.
Gerber Martina, Fischer Andrea, Jagannathan Vidhya, Drögemüller Michaela, Drögemüller Cord, Schmidt Martin J, Bernardino Filipa, Manz Eberhard, Matiasek Kaspar, Rentmeister Kai, Leeb Tosso. A deletion in the VLDLR gene in Eurasier dogs with cerebellar hypoplasia resembling a Dandy-Walker-like malformation (DWLM). PLoS One. 2015 Feb 10;10(2):e0108917. doi: 10.1371/journal.pone.0108917. eCollection 2015.
Din privatliv, dit valg
Vi bruger vigtige cookies til at drive hjemmesiden. Valgfrie cookies (såsom udbydere af integreret indhold) er deaktiveret som standard og er kun aktiveret, hvis du er enig. Du kan til enhver tid ændre dit valg ved at bruge knappen "Cookies".
Nødvendig for kernefunktioner og sikkerhed. Altid aktiveret.
Forbedrer funktioner som præferencegemning eller ikke-reklameindhold.
Hjælper os med at forstå brugen af siden. Deaktiveret som standard.
Reklame/sporing på tværs af sider (nogle video/kort indlejrede). Deaktiveret som standard.